WELL Health Technologies (TSE:WELL - Free Report) had its target price lowered by Stifel Nicolaus from C$10.00 to C$9.00 in a research report sent to investors on Wednesday,BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.
WELL has been the subject of a number of other reports. Ventum Financial decreased their price objective on WELL Health Technologies from C$8.00 to C$7.60 and set a "buy" rating for the company in a report on Wednesday, April 16th. Scotiabank reduced their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set an "outperform" rating for the company in a report on Wednesday, April 16th. Royal Bank of Canada dropped their price target on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an "outperform" rating on the stock in a research report on Monday, March 31st. Raymond James raised their price objective on shares of WELL Health Technologies from C$10.00 to C$11.00 in a research note on Tuesday, December 17th. Finally, TD Securities decreased their price target on WELL Health Technologies from C$8.50 to C$7.50 and set a "buy" rating for the company in a research note on Wednesday, April 16th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of C$8.08.
Check Out Our Latest Stock Report on WELL Health Technologies
WELL Health Technologies Stock Performance
Shares of WELL Health Technologies stock traded down C$0.19 during trading on Wednesday, hitting C$3.77. 1,110,064 shares of the stock were exchanged, compared to its average volume of 1,005,995. The stock has a market cap of C$942.21 million, a PE ratio of 12.77, a P/E/G ratio of -1.93 and a beta of 1.20. The stock's fifty day moving average is C$5.07 and its 200 day moving average is C$5.56. WELL Health Technologies has a 12 month low of C$3.48 and a 12 month high of C$7.36. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14.
WELL Health Technologies Company Profile
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Articles

Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.